ACEI/ARB use and risk of infection or severity or mortality of COVID-19: A systematic review and meta-analysis

The effects of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) on the risk of COVID-19 infection and disease progression are yet to be investigated. The relationship between ACEI/ARB use and COVID-19 infection was systematically reviewed. To identify relevan...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xue, Yu, Jiong, Pan, Li-ya, Jiang, Hai-yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227582/
https://www.ncbi.nlm.nih.gov/pubmed/32422341
http://dx.doi.org/10.1016/j.phrs.2020.104927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227582/
https://www.ncbi.nlm.nih.gov/pubmed/32422341
http://dx.doi.org/10.1016/j.phrs.2020.104927

Ejemplares similares